|
ALS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95987670537079E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.37369999503912E-08 |
| Normal-vs-Stage2 |
1.164110E-04 |
| Normal-vs-Stage3 |
1.81032966395378E-12 |
| Normal-vs-Stage4 |
3.93829413525282E-12 |
| Stage1-vs-Stage2 |
4.026400E-01 |
| Stage1-vs-Stage3 |
2.739700E-03 |
| Stage1-vs-Stage4 |
1.855650E-03 |
| Stage2-vs-Stage3 |
2.000800E-01 |
| Stage2-vs-Stage4 |
1.165600E-01 |
| Stage3-vs-Stage4 |
5.965400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38222766565832E-13 |
| Normal-vs-AfricanAmerican |
4.846200E-04 |
| Normal-vs-Asian |
7.297200E-01 |
| Caucasian-vs-AfricanAmerican |
5.480800E-01 |
| Caucasian-vs-Asian |
1.135820E-01 |
| AfricanAmerican-vs-Asian |
2.841600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.962500E-04 |
| Male-vs-Female |
3.91370000000224E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.153800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.13170028903653E-10 |
| Normal-vs-Age(61-80Yrs) |
1.08559827793897E-11 |
| Normal-vs-Age(81-100Yrs) |
7.763700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.459200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.824200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.063200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.388400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.536800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.918200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.185800E-01 |
| Normal-vs-Grade 2 |
2.8503000004676E-07 |
| Normal-vs-Grade 3 |
4.33297842050706E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
3.043200E-01 |
| Grade 1-vs-Grade 3 |
6.133600E-02 |
| Grade 1-vs-Grade 4 |
3.175900E-04 |
| Grade 2-vs-Grade 3 |
2.370300E-02 |
| Grade 2-vs-Grade 4 |
3.37310000042557E-07 |
| Grade 3-vs-Grade 4 |
2.024100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.86180000000458E-05 |
| Normal-vs-ccB subtype |
1.73017156157584E-12 |
| ccA subtype-vs-ccB subtype |
1.577380E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.80000031441341E-10 |
| Normal-vs-N1 |
2.644500E-03 |
| N0-vs-N1 |
3.005800E-01 |
|
|
